About
Osteoboost is a groundbreaking FDA-cleared medical wearable designed to combat osteopenia—low bone density that often precedes osteoporosis—in postmenopausal women. Cleared through the FDA's De Novo pathway as a first-of-its-kind device, it offers a drug-free, prescription-based alternative to pharmaceutical treatments for bone loss. The device delivers precision vibration therapy directly to the spine and hips, stimulating bone-building cells (osteoblasts) through targeted mechanical stimulation. The science behind Osteoboost draws on more than a decade of independent research and was originally inspired by NASA studies on counteracting bone loss in astronauts during spaceflight. In a rigorous 12-month randomized clinical trial, women who used Osteoboost at least three times per week experienced 85% less vertebral bone density loss, 83% less vertebral bone strength loss, and 55% less hip bone density loss compared to a placebo control group—with no device-related serious adverse events reported. Designed for real-life usability, Osteoboost can be worn while walking, cooking, or going about a morning routine—requiring only 30 minutes per day. It is available by prescription and can be ordered online. Named a TIME Best Invention of 2025, Osteoboost fills a critical gap in early-stage bone health care, empowering postmenopausal women and their clinicians to act before fractures or severe osteoporosis occur.
Key Features
- FDA-Cleared Precision Vibration Therapy: Cleared through the FDA's De Novo pathway, Osteoboost delivers targeted mechanical vibration stimulation to the spine and hips to activate bone-building cells and slow bone density loss.
- Clinically Proven Efficacy: A 12-month randomized controlled trial demonstrated up to 85% reduction in vertebral bone density loss and 83% reduction in vertebral bone strength loss compared to a placebo group.
- Drug-Free Prescription Treatment: Osteoboost provides an evidence-based, pharmaceutical-free option for postmenopausal women with osteopenia, prescribed by clinicians as an early-stage bone health intervention.
- Inspired by NASA Bone Research: The vibration science powering Osteoboost is rooted in NASA research originally developed to counteract bone loss experienced by astronauts in zero-gravity environments.
- Easy 30-Minute Daily Routine: The wearable device integrates into everyday life—worn during walking, cooking, or morning routines—requiring only 30 minutes per day to achieve therapeutic benefits.
Use Cases
- Postmenopausal women with osteopenia seeking a drug-free, FDA-cleared alternative to pharmaceutical bone density treatments.
- Clinicians looking for a validated early-stage intervention to prescribe to patients with low bone density before osteoporosis or fractures develop.
- Women who want to maintain long-term independence and mobility by proactively protecting bone strength as they age.
- Patients who are unable or unwilling to use bisphosphonates or other bone medications due to side effects or contraindications.
- Healthcare providers managing postmenopausal bone health who need an evidence-based, non-pharmacological treatment option backed by FDA clearance and clinical trial data.
Pros
- Strong Clinical Evidence: Backed by a rigorous 12-month FDA-reviewed clinical trial with statistically significant reductions in bone density and strength loss, giving patients and physicians high confidence.
- No Serious Adverse Events: The clinical trial reported zero device-related serious adverse events, making it a safe option compared to some pharmaceutical alternatives with systemic side effects.
- First-of-Its-Kind FDA Clearance: As the only FDA-cleared device for osteopenia, Osteoboost fills a previously unmet clinical need, providing physicians a validated early-intervention tool before osteoporosis sets in.
- Practical and Non-Invasive: Feels like a gentle massage during use, requires no injections or daily pills, and fits naturally into a patient's daily routine, supporting long-term adherence.
Cons
- Prescription Required: Osteoboost is a prescription medical device, meaning patients must obtain approval from a licensed clinician before purchase, adding a step to access.
- Indicated for a Specific Population: Currently indicated only for postmenopausal women with osteopenia, limiting its applicability to other demographics such as men or premenopausal women with bone density concerns.
- Consistent Use Required: Clinical results were observed in women who used the device at least 3 times per week; irregular use may significantly reduce therapeutic effectiveness.
Frequently Asked Questions
What is Osteoboost and how does it work?
Osteoboost is an FDA-cleared wearable device that delivers precision vibration therapy to the spine and hips. The vibrations stimulate bone-building cells (osteoblasts), slowing the rate of bone density loss in postmenopausal women diagnosed with osteopenia.
Do I need a prescription to get Osteoboost?
Yes. Osteoboost is a prescription medical device. You will need a prescription from a licensed healthcare provider before you can order the device online.
How long do I need to use Osteoboost each day?
The recommended usage is 30 minutes per day. Clinical trial results were strongest among women who used it at least 3 times per week.
Is Osteoboost safe? Are there any side effects?
In the 12-month clinical trial, there were no device-related serious adverse events. Many users describe the sensation as similar to a light massage. It is drug-free and non-invasive.
Who is Osteoboost designed for?
Osteoboost is specifically designed and FDA-cleared for postmenopausal women diagnosed with osteopenia (low bone density that has not yet progressed to osteoporosis), serving as an early-stage intervention to slow further bone loss.
